Cargando…

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, (https://doi.org/10.1111/cns.13227). The above article published online on 02 October 2019 in Wiley Online Library (wileyonlinelib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jia, Zuo, Jie, Wang, Mao‐De, Xie, Wan‐Fu, Bai, Xiao‐Bin, Ma, Xu‐Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298975/ https://www.ncbi.nlm.nih.gov/pubmed/31578804 http://dx.doi.org/10.1111/cns.13227

Ejemplares similares

Retracted: Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma
por: Wang, Jia, et al.
Publicado: (2019)

Retracted: High SIRPA Expression Predicts Poor Prognosis and Correlates with Immune Infiltrates in Patients with Esophageal Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction of “Novel Bioluminescent Activatable Reporter for Src Tyrosine Kinase Activity in Living Mice”
por: Leng, Weibing, et al.
Publicado: (2020)

Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Engineering, Journal of Healthcare
Publicado: (2023)

Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Markers, Disease
Publicado: (2023)

Retracted: Abnormal COX2 Protein Expression May Be Correlated with Poor Prognosis in Oral Cancer: A Meta-Analysis
por: International, BioMed Research
Publicado: (2021)

Retraction: Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase
por: Cerchia, Laura, et al.
Publicado: (2015)

[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2023)

The Receptor Tyrosine Kinase AXL in Cancer Progression
por: Rankin, Erinn B., et al.
Publicado: (2016)

Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis
Publicado: (2020)

Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Analysis of Risk Factors for Intraoperative Hypotension in Cesarean Section and Poor Prognosis of Neonates
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Retracted: Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer
por: Markers, Disease
Publicado: (2023)

Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma
por: Scherschinski, Lea, et al.
Publicado: (2022)

Retraction: Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
Publicado: (2022)

Retracted: High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Receptor tyrosine kinases in carcinogenesis
por: Zhang, Xiao-Ying, et al.
Publicado: (2020)

Retraction statement: A kinase‐interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients
Publicado: (2021)

Retracted: Low Serum Albumin Is Associated with Poor Prognosis in Patients Receiving Peritoneal Dialysis Treatment
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Correlation between Breast Ultrasound Microcalcification and the Prognosis of Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction: A Cross-Talk between TrkB and Ret Tyrosine Kinases Receptors Mediates Neuroblastoma Cells Differentiation
Publicado: (2022)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
por: Wu, Xinyan, et al.
Publicado: (2021)

Retracted: AXL Inhibits Proinflammatory Factors to Relieve Rheumatoid Arthritis Pain by Regulating the TLR4/NF-κB Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: miRNA-448 Regulates the Development of Glioblastoma (GBM) by Regulating Rho-Associated Protein Kinase 1
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retraction: Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients
Publicado: (2018)

Retracted: Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Study on the Correlation Factors of Tumour Prognosis after Intravascular Interventional Therapy
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors
por: Yuan, Jie, et al.
Publicado: (2021)

Long Noncoding RNA SNHG15 Serves as an Oncogene and Predicts Poor Prognosis in Epithelial Ovarian Cancer [Retraction]
Publicado: (2023)

Axl receptor tyrosine kinase is a regulator of apolipoprotein E
por: Zhao, Wenchen, et al.
Publicado: (2020)

Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients—An Integrated Bioinformatics Approach
por: Markers, Disease
Publicado: (2023)

PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer: Retraction
por: Li, Ming, et al.
Publicado: (2023)

Retracted: Correlations of Ezrin Expression with Pathological Characteristics and Prognosis of Osteosarcoma: A Meta-Analysis
por: Journal, The Scientific World
Publicado: (2022)

[Retracted] P21 activated kinase 2 promotes pancreatic cancer growth and metastasis
por: Yao, Guo-Wang, et al.
Publicado: (2023)

[Retracted] Expression and function of PIM kinases in osteosarcoma
por: Mou, Shuai, et al.
Publicado: (2023)

Retraction: MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression
Publicado: (2022)

Retraction Notice to: Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration
por: Li, Qiuli, et al.
Publicado: (2022)

Retracted: PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4375r98d2hr5c8ac3503mbvcb7